JCI Insight

SJR Rank #800H-index: 144SJR: 2.827Best quartile: Q1Open AccessAPC: US$4,100Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

American Society for Clinical Investigation

Country

United States

Type

journal

SJR by Edition

2022202500.851.72.553.4

Subject Categories

  • Medicine (miscellaneous)Q1

Areas: Medicine

Most published research topics

Immune Cell Function and InteractionT-cell and B-cell ImmunologyImmunotherapy and Immune ResponsesImmune cells in cancerPancreatic function and diabetesCancer Immunotherapy and BiomarkersCAR-T cell therapy researchSARS-CoV-2 and COVID-19 ResearchNeonatal Respiratory Health ResearchImmune Response and Inflammation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs040080012001600

Documents per Year

202220250150300450600

Detailed Information

ISSN

2379-3708

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

6.38

References per Document

57.28

Coverage

2016-2026

Scope

Papers submitted to JCI Insight should present a focused line of investigation that provides meaningful and impactful contributions to the understanding of the biology of disease or new therapeutic opportunities. JCI Insight articles may build on existing paradigms in the field or provide hypothesis-generating findings (see editorial). Examples of studies suitable for JCI Insight include, but are not limited to, human genetics research, new mouse models of disease, in vivo studies of disease mechanisms, precision medicine, clinical and biomarker studies, and studies that provide new resources for the biomedical research community. Studies should include a relevant in vivo model system and/or a primary human cell or tissue model.

Metrics from SCImago Journal Rank 2025. View on SCImago